大麻素和ADHD:神经药理学的新前沿?
Helia Mavaddat1,2, Abtin Fouladi3,2, Ayeh Sabbagh Kashani1,2
1Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
大麻素显示出治疗注意力缺陷多动症 (ADHD) 症状的潜力. 研究探讨了大麻化合物如何帮助管理ADHD,提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 注意缺陷多动障碍 (ADHD) 是一种神经发育障碍,影响注意力,冲动性和多动性.
- 患有多动症的个体在日常生活中面临挑战,并有更高的物质使用风险,包括大麻.
- 大麻有时被ADHD患者用于自我治疗,以缓解症状或药物的副作用.
研究的目的:
- 综合审查有关大麻素对ADHD影响的现有文献.
- 探索大麻素对ADHD症状的潜在治疗益处.
- 阐明在ADHD中大麻素作用背后的药理机制.
主要方法:
- 在体内和临床研究的文献综述.
- 对ADHD患者和动物模型中的大麻素,包括大麻二醇的研究分析.
- 检查假设的自我治疗行为和症状缓解.
主要成果:
- 大麻素,如大麻,在与ADHD相关的临床前和临床研究中显示出潜在的治疗效果.
- 有证据表明,大麻素可能有助于管理与ADHD相关的焦虑和药物副作用.
- 需要进一步的研究才能充分理解疗效和机制.
结论:
- 大麻素代表了新的多动症治疗策略的潜在领域.
- 了解大麻素的药理作用对于开发有效的治疗方法至关重要.
- 该审查强调需要继续调查基于大麻的多动症干预措施.
更多相关视频
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
03:43Oromucosal as an Alternative Method for Administration of Cannabis Products in Rodents
Published on: August 22, 2025
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Drug Abuse and Addiction: Pharmacological Phenomena
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Affecting Neurotransmitter Release or Uptake
